Health product recall

Glucagon (2021-09-25)

Starting date:
September 25, 2021
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-76509

Last updated: 2021-09-27

Summary

  • Product: Glucagon

Reason

Eli Lilly is recalling lot D239382A to the retail level because of a product complaint reporting that the vial of Glucagon was in liquid form instead of the powder

Depth of distribution

Retailers

Affected products

Glucagon

DIN, NPN, DIN-HIM

DIN 02243297

Dosage form

Powder for solution, kit

Strength

Glucagon (Recombinant DNA Origin) 1mg/vial

Lot or serial number

D239382A

Companies

Recalling Firm
Eli Lilly Canada Inc.
130 King Street West, Exchange Tower, Suite 900
Toronto
M5X 1B1
Ontario
CANADA
Marketing Authorization Holder
Eli Lilly Canada Inc.
130 King Street West, Exchange Tower, Suite 900
Toronto
M5X 1B1
Ontario
CANADA

Report a problem or mistake on this page
What was wrong?

If you want to receive a follow-up reply, please include your name and e-mail address.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Date modified: